论文信息 - Male breast cancer after finasteride therapy for benign prostate hyperplasia - 字舞流文

Male breast cancer after finasteride therapy for benign prostate hyperplasia

Y. Lo | C. Chi | Jui-Ming Liu | Y. Chiang | Chih-Yuan Chou | Chen Chi

[1] S. Pal,et al. Male breast cancer: an update in diagnosis, treatment and molecular profiling. , 2010, Maturitas.

[2] G. Maddern,et al. Are males with early breast cancer treated differently from females with early breast cancer in Australia and New Zealand? , 2009, Breast.

[3] A. Kucuk,et al. Male breast cancer: a retrospective analysis. , 2009, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[4] Y. Erhan,et al. Invasive lobular carcinoma of the male breast. , 2006, Canadian journal of surgery. Journal canadien de chirurgie.

[5] A. Patchefsky,et al. Case report 3 , 1976, Skeletal Radiology.

[6] C. Roehrborn,et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. , 2003, The New England journal of medicine.

[7] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[8] J. Donohue,et al. Molecular markers in male breast carcinoma , 1998, Cancer.

[9] G. Ribeiro,et al. Adjuvant tamoxifen for male breast cancer (MBC). , 1992, British Journal of Cancer.